Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia by FLT3 tyrosine kinase inhibitors
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F20%3A00013031" target="_blank" >RIV/00023736:_____/20:00013031 - isvavai.cz</a>
Result on the web
<a href="https://novapublishers.com/shop/hematologic-malignancies-an-overview/" target="_blank" >https://novapublishers.com/shop/hematologic-malignancies-an-overview/</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Targeting oncogenic signaling in mutant FLT3 acute myeloid leukemia by FLT3 tyrosine kinase inhibitors
Original language description
McDonough strain of feline sarcoma virus-related tyrosine kinase 3 receptor mutations are present in about 30-35 pcts of AML patients. FLT3 is a class III family transmembrane tyrosine kinase receptor which serves an important role in normal hematopoietic cell survival and proliferation.
Czech name
—
Czech description
—
Classification
Type
C - Chapter in a specialist book
CEP classification
—
OECD FORD branch
30205 - Hematology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Book/collection name
Hematological malignancies: an overview
ISBN
978-1-53618-124-1
Number of pages of the result
38
Pages from-to
89-127
Number of pages of the book
338
Publisher name
Nova Science
Place of publication
New York
UT code for WoS chapter
—